| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.067 | 0.03 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.28 | 0.03 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.13 | 0.03 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.03 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.25 | 0.03 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.069 | 0.04 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.04 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.12 | 0.04 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.08 | 0.04 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.075 | 0.04 |